Stockreport

Sarepta and Roche aim to resume paused Elevidys trials following patient death [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Three European studies, notably the Envol study (NCT06128564); the Envision study (NCT05881408); and study 104 (NCT06241950), were paused on request by the European Uni [Read more]